The latest cancer drugs news
Browsing: Cancer Drug News
FDA approves darolutamide tablets for metastatic hormone-sensitive prostate cancer
On August 5, 2022, the Food and Drug Administration approved darolutamide tablets in combination with docetaxel…
FDA approves fam-trastuzumab deruxtecan-nxki for HER2-low breast cancer
On August 5, 2022, the Food and Drug Administration approved fam-trastuzumab deruxtecan-nxki for adult patients…
Leukemia vulnerability discovered causing drug sensitivity
All human tumours originating from various tissues share a series of properties that define them,…
CAR T-Cell therapy axicabtagene ciloleucel has been granted European marketing authorisation for the treatment of r/r follicular lymphoma
European Commission (EC) has approved CAR T-cell therapy axicabtagene ciloleucel for the treatment of adult patients with…
Poziotinib is active in EGFR exon 20 mutant non-small cell lung cancer with efficacy highly dependent on insertion location
A Phase II clinical trial of poziotinib for non-small cell lung cancer (NSCLC) with epidermal…
NICE recommends nivolumab for use post-surgery in specific urothelial cancer patients
It has been announced that the National Institute for Health and Care Excellence (NICE) has…
Research suggests novel combination therapy for triple-negative breast cancer
Research led by Suresh Alahari, PhD, Professor of Biochemistry at LSU Health New Orleans schools…
Long term benefits for chronic lymphocytic leukaemia patients
Chronic lymphocytic leukaemia (CLL) patients who are refractory or resistant to treatment can be encouraged…
EMA recommends olaparib for treatment of high-risk, early breast cancer
The Institute of Cancer Research, London, strongly welcomes the news that olaparib has been recommended…
NICE recommends abemaciclib in combination with endocrine therapy for adjuvant treatment of HR+/HER2- early breast cancer
Abemaciclib in combination with endocrine therapy is the first CDK4/6 inhibitor to be made available within…